Viewing Study NCT00913120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-07-03 @ 4:29 PM
Study NCT ID: NCT00913120
Status: COMPLETED
Last Update Posted: 2010-06-09
First Post: 2009-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None YM150 View
None FXa inhibitor View
None Thrombosis View
None Anticoagulant View
None Venous thromboembolism View
None Arthroplasty, replacement, hip View